Clinical Trials Browser

Phase 1/2 × Leukemia, Lymphocytic, Chronic, B-Cell × laromustine × Clear all

NCT00304005 2013-07-18

VNP40101M in Treating Patients With Richter Syndrome or Refractory or Relapsed Chronic Lymphocytic Leukemia or Other Lymphoproliferative Disorders

Phase 1/2 Completed

LymphoidOther hematologic neoplasm

Hodgkin Disease, Leukemia, Lymphoma, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Large B-Cell, Diffuse